New Technology– category –
-
CuraCell Pursues Gentler Preconditioning and Reduced Manufacturing Costs for CC-38 TIL Therapy for Solid Tumors, Enhancing Patient Eligibility and Cost-Effectiveness
Clinical Leader USA Overview CuraCell is focusing on a gentler preconditioning regimen and reduced manufacturing costs for its CC-38 T cell therapy program, which utilizes patient-derived tumor-infiltrating lymphocytes (TILs) for solid t... -
US Department of Energy’s ‘GENESIS MISSION’ Aims for Bioprocess Autonomy via AI and Digital Twins, Targeting Enhanced Yields and Cost Reduction
Department of Energy USA Overview The U.S. Department of Energy's 'GENESIS MISSION' seeks to connect biological design with manufacturing outcomes by integrating AI with experiments, structural analysis, models, biodiversity discovery, a... -
Scaling Animal-Free Proteins from Precision Fermentation Faces Challenges: Cost and Process Control Barriers from Lab to Market
MDPI Switzerland Overview Scaling animal-free proteins produced via precision fermentation from lab to industrial production faces significant challenges, including maintaining strain performance, high media costs, and precise bioprocess... -
Allogeneic CAR-T Manufacturing: Unlocking Rapid, Off-the-Shelf Cancer Therapy
Liv Hospital Turkey Overview Allogeneic CAR-T cell manufacturing is poised to revolutionize cancer treatment by providing 'off-the-shelf' solutions derived from healthy donor cells. This approach dramatically shortens treatment timelines... -
Beckman Coulter Showcases BioLector XT Micro Bioreactor and Biomek i5 Automated Liquid Handler to Accelerate Precision Fermentation and Alternative Protein Research
Beckman Coulter Life Sciences (YouTube) USA Overview Chris Saenz of Beckman Coulter Life Sciences introduced key technologies accelerating early-stage microbiology engineering for precision fermentation and alternative proteins. The BioL... -
Methodist Healthcare Expands CAR T-Cell Therapy Trials Beyond Cancer to Autoimmune Diseases like Lupus and MS, Including Pediatric Patients
San Antonio Report USA Overview Methodist Healthcare is expanding CAR T-cell therapy clinical trials beyond oncology, actively researching applications for autoimmune diseases such as Systemic Lupus Erythematosus (SLE) and Multiple Scler... -
Widespread Global Disparities in CAR T-Cell Therapy Access Highlighted; In Vivo CAR-T, Allogeneic Platforms, and Rapid Manufacturing Emerge as Potential Solutions
ASH Clinical News USA Overview Significant global disparities in CAR T-cell therapy access are attributed to high costs, manufacturing complexities, and limited healthcare infrastructure. Novel scientific strategies, including in vivo CA... -
EU-Funded S.O.L.A.R.I.S. Project Launched to Enhance Scalability, Efficiency, and Sustainability of CAR T Cell Manufacturing Across Europe
Green Elephant Biotech Germany Overview The EU-funded S.O.L.A.R.I.S. Project has commenced with 13 partners, including Green Elephant Biotech and Miltenyi Biotec, aiming to develop and implement new approaches for scalable, efficient, an... -
New Manufacturing-Scale Cell Culture Media Preparation Guide Optimizes Quality and Efficiency with WFI Temperature Control (15-25°C) and Filtration Sizing (0.5-2m²/1000L)
BioProcess Tools Global Overview A new guideline for manufacturing-scale cell culture media preparation emphasizes that media quality directly impacts cell growth, viable cell density, and product titer. Achieving pharmaceutical-grade pr... -
FBS-Free Glioblastoma Models: A Leap Forward for Reproducibility and Ethical Drug Discovery
MDPI Academic paper Overview A new study successfully evaluates fetal bovine serum (FBS) alternatives for glioblastoma cell culture in advanced biomaterial-based 2D and 3D tumor models, addressing critical ethical and standardization con...
